Back to search

Article

Effects of omalizumab treatment on gut microbiome in adolescent patients with chronic spontaneous urticaria

2022-04-19

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Omalizumab is a humanized anti-immunoglobulin (Ig)E monoclonal antibody that is effective for some patients with chronic spontaneous urticaria (CSU) who do not respond to antihistamines. However, the mechanism by which omalizumab improves urticaria remains obscure. Gut microbiome plays a role in the pathogenesis of allergies. Here, we aimed<bold> </bold>to inves...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d200b615-231c-5326-a871-c75b98e502de
DOI
10.21203/rs.3.rs-1561183/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of omalizumab treatment on gut microbiome in adolescent patients with chronic spontaneous urticariaDOI 10.21203/rs.3.rs-1561183/v1
Select a neighboring publication to make it the new centre.